Vascular &
Endovascular Surgery

Ronald L. Dalman MD

Academic Appointments

Contact Information

  • Clinical Offices
    Vascular Center 300 Pasteur Dr H3642 MC 5642 Stanford, CA 94305
    Tel Work (650) 725-5227 Fax (650) 498-6044
  • Academic Offices
    Personal Information
    Email Tel (650) 721-6709
    Administrative Contact
    Barbara Munoz Tel Work 650-721-6709
    Not for medical emergencies or patient use

Professional Snapshot

Clinical Focus

  • Vascular Surgery
  • Aortic Aneurysm
  • Limb Salvage
  • Aortic Diseases
  • Aorta, Abdominal
View all 21clinical focus of Ronald Dalman

Administrative Appointments

  • Program Director, Vascular Surgery Residency Program, Stanford University School of Medicien (2005 - present)
  • Director, Vascular Center, Stanford Hospital and Clinics (2005 - present)
  • Professor and Chief, Division of Vascular Surgery, Stanford University School of Medicine (2005 - present)

Honors and Awards

  • Chair, Research Council, Society for Vascular Surgery (2008-2010)
  • Ad hoc member, Biotechnology and Surgical Sciences Study Section, Center for Scientific Review, NIH (2003-2005)
  • President, Silicon Valley Affiliate, American Heart Association (1999-2000)
  • Chairman, Membership Committee, Society for Vascular Surgery (2001)
  • E. J. Wylie Travelling Fellowship in Vascular Surgery, Lifeline Foundation (2000 -2001)

Professional Education

Board Certification: Vascular Surgery, American Board of Surgery (1992)
Residency: Oregon Health Sciences Univ Hospital, OR (1991)
Board Certification: General Surgery, American Board of Surgery (1990)
Residency: University of Washington Medical Center, WA USA (1989)
Internship: U. Washington, (1985)
View All 10

Postdoctoral Advisees

Monica Dua , Noriyuki Miyama

Graduate & Fellowship Program Affiliations

Community & International Work

Scientific Focus

Research Interests

We are investigating the biologic and mechanical basis of aneurysmal degeneration of the aorta. We use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.

By extension we are keenly interested in new surgical technology and its application to aneurysmal and
occlusive arterial and venous diseases. To this end we have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. We are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.

Stanford Medicine Resources:

Footer Links: